Diabetes
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Plasma miR-409-3p levels gradually decreased during diabetes development and improved with disease remission after anti-CD3 antibody therapy.
|
31659408 |
2020 |
Diabetes Mellitus
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Plasma miR-409-3p levels gradually decreased during diabetes development and improved with disease remission after anti-CD3 antibody therapy.
|
31659408 |
2020 |
Diabetes Mellitus, Insulin-Dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
We propose that miR-409-3p may represent a new circulating biomarker of islet inflammation and type 1 diabetes severity.
|
31659408 |
2020 |
Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Our previous study showed that the expression level of miR-409-5p was stably downregulated in the early stage of APP/PS1 double transgenic mice model of AD.
|
31849582 |
2019 |
Malignant neoplasm of endometrium
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings indicated that miR‑409 targeted the Smad2 transcript and suppressed endometrial cancer cell growth, suggesting that miR‑409 has a tumor suppressive role in the pathogenesis of human endometrial cancer.
|
30431090 |
2019 |
Malignant tumor of cervix
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hence, miR-409-3p may represent a useful early marker and a potential therapeutic target for cervical cancer.
|
30711417 |
2019 |
Encephalomyelitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
In contrast, simultaneously silenced miR-409-3p and miR-1896 co-operatively ameliorates inflammation and demyelination in the central nervous system of EAE mice.
|
30294880 |
2019 |
Liver neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Meanwhile, microRNA-409 expression in hepatoma cell lines was also strikingly lower than that in normal liver cells.
|
30657556 |
2019 |
Multiple Sclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Co-inhibition of miR-409-3p and miR-1896 may be a therapeutic target for treating MS and neuroinflammation.
|
30294880 |
2019 |
Osteoporosis, Postmenopausal
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, targeting miR-409-5p may be helpful in increasing bone density in conditions like post menopausal osteoporosis.
|
31165485 |
2019 |
Polycystic Ovary Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Effect of microRNA-409 on the pathogenesis of polycystic ovary syndrome.
|
30915729 |
2019 |
Adult Liver Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Compared with paracancerous and normal liver tissues, the level of microRNA-409 was remarkably reduced in hepatocarcinoma tissues and was negatively correlated with tumor stage, tumor size and overall survival time of patients with liver cancer.
|
30657556 |
2019 |
Liver and Intrahepatic Biliary Tract Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Compared with paracancerous and normal liver tissues, the level of microRNA-409 was remarkably reduced in hepatocarcinoma tissues and was negatively correlated with tumor stage, tumor size and overall survival time of patients with liver cancer.
|
30657556 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Phosphoinositide-dependent kinase 1-associated glycolysis is regulated by miR-409-3p in clear cell renal cell carcinoma.
|
30218446 |
2019 |
High-Grade Squamous Intraepithelial Lesions
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
|
30711417 |
2019 |
Malignant neoplasm of liver
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Compared with paracancerous and normal liver tissues, the level of microRNA-409 was remarkably reduced in hepatocarcinoma tissues and was negatively correlated with tumor stage, tumor size and overall survival time of patients with liver cancer.
|
30657556 |
2019 |
Endometrial Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings indicated that miR‑409 targeted the Smad2 transcript and suppressed endometrial cancer cell growth, suggesting that miR‑409 has a tumor suppressive role in the pathogenesis of human endometrial cancer.
|
30431090 |
2019 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Meanwhile, microRNA-409 expression in hepatoma cell lines was also strikingly lower than that in normal liver cells.
|
30657556 |
2019 |
cervical cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hence, miR-409-3p may represent a useful early marker and a potential therapeutic target for cervical cancer.
|
30711417 |
2019 |
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, clinical data showed that NSCLC patients with high levels of miR-409 experienced significantly better survival. miR-409 expression was also negatively associated with SPIN1 expression.
|
30290307 |
2018 |
Lymphatic Metastasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Additionally, a tumor xenograft model was constructed to examine the effects of miR-409-3p on the tumor growth and lymphatic metastasis in nude mice.
|
29928443 |
2018 |
Squamous cell carcinoma of tongue
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A significant downregulation was detected in miR-409-3p expression in TSCC tissues and cells (all P<0.05) compared with normal tongue mucosa tissues and cell line, which was associated with lymph node metastasis and tumor-node metastasis staging (both P<0.05).
|
29928443 |
2018 |
Progression of non-small cell lung cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
LncRNA ZEB1-AS1/miR-409-3p/ZEB1 feedback loop is involved in the progression of non-small cell lung cancer.
|
30448056 |
2018 |
Idiopathic Pulmonary Fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Overall, the present incorporated network illustrated the key link between miRNA and genes in IPF; in particular, it was elucidated that miR‑409‑5p and has‑miR‑376c, together with their target genes (C‑C motif chemokine ligand 20 and oncostatin M), are likely candidates involved in the promotion of IPF initiation and progression.
|
30221703 |
2018 |
Cone-Rod Dystrophy 2
|
0.010 |
Biomarker
|
disease |
BEFREE |
MicroRNA-409 promotes recovery of spinal cord injury by regulating ZNF366.
|
29949136 |
2018 |